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Supported by the European National
Dermatological Societies, EADV, UEMS
and ESDR
The European Journal of Dermatology and the European
Dermatology Forum have agreed to reproduce, with per-
mission, the White Book© 2005 ABW Wissenschaftsver-
lag GmbH.
This work was a joint enterprise bringing together many
European dermatologists, chosen to obtain a broad repre-
sentation from across Europe and according to their exper-
tise. Although the content of the “White Book” was prima-
rily intended for non-dermatologists it is felt that it will also
prove valuable to all our colleagues.
In this second part, the EDF presents two further chapters
from “The many faces of dermatology” – “Environmen-
tal hazards and the skin” and “Occupational skin
diseases”.
Environmental hazards and the skin
C. Piérard-Franchimont, P. Quatresooz, E. Berardesca,
G. Plomteux, G.E. Piérard.
Introduction
The skin plays many roles important for life. One of the
most vital is its barrier function between a constant internal
milieu and the potentially hostile outside environment.
Many other major professional groups, including toxicolo-
gists, internists, environmental scientists, pharmacologists,
oncologists and microbiologists have joined with derma-
tologists to study this interplay.
The major impetus to study various environmental effects
has been the dramatic rise in incidence in disorders result-
ing from interaction between the environment and the skin.
Skin cancers, various forms of dermatitis and exotic infec-
tions are forcing their attention on physicians. This has
generated a general concern particularly in Europe. Alter-
ations in the earth’s atmosphere and in the range and nature
of chemical substances and microorganisms that contact
human skin appear responsible. Most of these alterations
are man-made and in part due to changed changing social
and economic patterns.
Two major types of threats to the skin can be distinguished.
Physical damage includes trauma and electromagnetic ra-
diation including ultraviolet light. The other category in-
cludes chemical insults by exogenous compounds called
xenobiotics. The uppermost part of the skin – the stratum
corneum – is the main barrier against xenobiotics. Derma-
tologists have long studied the barrier function of the stra-
tum corneum.
Skin barrier structure and function
Forming the interface with a desiccating external environ-
ment, the stratum corneum retards evaporative water loss
from the internal milieu of the body. The stratum corneum
also protects against mechanical insults and the ingress of
xenobiotics and microorganisms. It also provides the first
line of defense against ultraviolet light, screening out most
ultraviolet B irradiation. The stratum corneum is about
10 lm thick and consists of flattened, dead keratinocytes,
called corneocytes, each of them surrounded by lipid lay-
ers. It has been likened to a brick wall, with its cells as
bricks and the lipids as mortar. The stratum corneum is
critical for maintaining the water balance. When it is com-
pletely removed, there is free evaporation, identical to that
from an open water surface, while under normal circum-
stances the skin barrier only allows a limited, controlled
evaporation. The rate of evaporation from the skin, com-
monly termed trans-epidermal water loss (TEWL), is a
sensitive indicator of the skin barrier function, which can be
measured in a non-invasive, objective and standardized
way.
The intercellular lipids, rather than the cells, play the cru-
cial rule in the water-retaining function of the skin barrier.
Selectively removing only the lipids from the stratum cor-
neum leads to free evaporation. The composition of the
barrier lipids is unique and quite different from the lipid
composition found in membranes elsewhere in the body.
Three main types of fatty substances (cholesterol, ceram-
ides and free fatty acids) make up 90% of the total amount
of barrier lipids. These lipids are produced in lamellar
bodies, small intracellular organelles within keratinocytes,
which discharge their contents into the intercellular spaces
to establish the barrier. Skin barrier problems are a feature
of many common skin disorders and may actually be the
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critical stimulus initiating the inflammatory response.
Damage to the skin barrier in itself results in release of
pro-inflammatory cytokines, but as the damage also leads
to increased penetration of allergens and irritants, a defi-
cient skin barrier also sustains an ongoing inflammatory
process. Consequently, skin barrier problems are a critical
factor in many kinds of dermatitis.
The skin barrier is continuously maintained through ho-
meostatic processes. Everyday wear-and-tear, such as fre-
quent washing of hands, and wet work may damage the
barrier. The resulting increase in TEWL stimulates the skin
to initiate barrier repair, which consists of release of the
lipid content of preformed lamellar bodies and acceleration
of the lipid synthesis. The result is a gradual normalization
of TEWL, provided there are not problems with the synthe-
sis of the lipids. If the necessary lipids cannot be synthe-
sized, TEWL remains continuously elevated, and the result
is chronic dry skin. This can be due either to an inborn
defect in the synthesis of one or more of the crucial lipids, a
dietary disturbance or even a temporary phenomenon, such
as the typical dry skin during winter.
There are two main types of cutaneous reactions to envi-
ronmental challenges. Both can appear clinically similar.
Irritant contact dermatitis (ICD) results from direct damage
to the skin caused by exogenous agents. Every person who
encounters a toxic substance in a high enough concentra-
tion experiences some damage. Examples from daily life
might include harsh soaps, acid added to swimming pools
or many industrial exposures. In contrast, allergic contact
dermatitis (ACD) only involves a limited number of indi-
viduals, is not concentration-dependent, and requires a
period of sensitization.
Every day the skin is exposed to hundreds of xenobiotics.
These include both naturally- occurring and synthetic sub-
stances in the environment, workplace and home. Skin
exposure to xenobiotics may be accidental or deliberate, but
in most cases, normal everyday skin exposures do not
present a toxicological risk. Some chemicals are local irri-
tants, while others are more often allergens. Some sub-
stances elicit first an irritant dermatitis and then later an
allergic form.
Irritant contact dermatitis. Two different pathways may be
involved in ICD. Acute ICD is characterized by an inflam-
matory reaction that mimics the typical expression of ACD,
and is associated with the release of inflammatory media-
tors and cytokines. Chronic ICD is characterized by dis-
turbed barrier function, associated with increased epider-
mal turnover leading clinically to lichenification
(thickening of the epidermis). Irritation normally starts at
the level of the stratum corneum and later involves the
dermis, whereas the inflammation of sensitization starts in
the dermis.
The variations in the skin reactions are dependent on the
degree of injury induced, as well as on the effect of an
irritant substance on different cell populations. The physi-
cochemical characteristics, the concentration, volume and
contact time of the irritant influence the skin response.
Furthermore, inter-individual differences exist based on
age, gender, skin typology, previous skin disease and a
range of genetic factors. In a given individual, reactivity
differs according to the skin thickness and body region.
Subjects suffering from atopic dermatitis, seborrheic der-
matitis, or with sensitive skin are reported to be more
susceptible to irritants. Testing for skin irritation can be
helpful in monitoring these conditions and identifying pa-
tients at risk for irritant contact dermatitis and/or with
sensitive skin.
Allergic contact dermatitis. ACD is a form of delayed Type
IV T-cell-mediated hypersensitivity. This condition follows
skin contact with small allergens that penetrate into the
skin. The skin response is a two-step reaction. The first or
sensitization phase occurs when the body generates a cir-
culating population of antigen-specific memory T cells
following exposure to a substance. The second or elicitation
phase occurs 48-72 hours after subsequent re-exposure to
the same substance, but only in sensitized individuals.
Elicitation involves cellular infiltration into the epidermis
that results into a cutaneous inflammatory reaction charac-
terized by erythema, edema and vesiculation.
Occupational contact dermatitis. Both ICD and ACD com-
bine to account for 90% of occupational dermatoses. Occu-
pational contact dermatitis is the most prevalent of all
occupational diseases in many countries. In western Eu-
rope, occupational contact dermatitis represents about one-
third of all registered occupational diseases.
Surfactants and the consumer. Surfactants are potentially
irritant agents that each of us encounters daily. Because of
their detergent and foaming properties, surfactants find
broad use in many domestic products (cosmetics and toilet-
ries, cleansing products, laundry products). Many surfac-
tants are classified, according to the Dangerous Substance
Directive (DSD), as irritant for the skin and for the eyes
[53]. It is not always clear why ingredients identified as
“irritants” are incorporated into consumer products. Such a
classification of surfactants is based on the hazards linked
to the individual substances (intrinsic irritation properties),
and does not take into account the interaction between the
ingredients of the product. The rules about informing con-
sumers about potential risks of irritation differ with the
product type, with substantial differences between cosmet-
ics as compared to household cleansers and detergents.
Different solutions exist to develop non-irritating
surfactant-based products. Careful selection of the mildest
surfactants is important. Combination of several adequate
surfactants may also be effective. Nonionic surfactants are
generally considered as the mildest, even if several of them
are classified as skin or eye irritant by the DSD, and are
usual ingredients in body cleansing products for babies, for
sensitive skin or for face-cleansing products. They are also
the usual ingredients in dishwashing liquids for sensitive
skin or in all-purpose cleaners for hard surfaces.
Several anionic surfactants are also well-tolerated by the
skin. They are also regularly used in facial cleansers or
products for baby care. These very mild anionic surfactants
are rarely used in household cleansers, as they clean poorly.
Amphoteric surfactants are never used alone, but rather in
combination, and they play no role in determining the
irritation potential of the finished product. Cationic surfac-
tants are usually used for their antibacterial properties
rather than their surface tension properties. While some are
quite irritating, there are others which are mild and well-
tolerated.
The best way to reduce the irritant effects of surfactants is to
combine several different agents with varying properties.
Thus the consumer should not be dismayed by long lists of
surfactants on package labels. Other additives are possible,
but usually less desirable, because of factors such as in-
creased costs or reduced consumer acceptance.
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Consumers and cosmetic products. The European Cos-
metic Directive (76/768/EEC) [54] states that the manufac-
turer or the person responsible of marketing of a cosmetic
product must keep readily accessible to the competent
authorities, for control purposes, the information concern-
ing the assessment of the safety for human health of the said
finished product. Existing data, if any, on undesirable ef-
fects on human health resulting from use of the cosmetic
products must also be accessible to the authority. This
means that the information regarding the safety of the
product exists but is not directly accessible to the consumer.
Nevertheless, many cosmetic products make label claims of
mildness, skin compatibility or similar virtues; these must
be scientifically proven. With the seventh amendment of the
Cosmetic Directive [51], the situation in Europe will
change. After 11 September 2004, product information will
have to be readily accessible to the public, but it will not
have to be present on the label.
Consumers and household cleansers. Whenever a house-
hold cleanser or laundry detergent is a potential skin irri-
tant, the consumer should be informed on the product label
about such a health hazard. This is done by printing a Saint
–Andrew cross, and a “R-38 skin irritant” symbol on the
label or package. The Dangerous Preparation Directive
(DPD, 1999/45/EC) [52] indicates which products must
carry such warnings and defines two basic procedures for
assessing health hazard, and in this case skin irritation
hazard:
1) Conventional calculation method which states that if
20% or more of ingredients of a finished product are clas-
sified as skin irritants, the product should be classified as
“skin irritant.”;
2) Toxicological determination of the skin irritation prop-
erties of the product by testing.
In addition the DPD requires that if data on humans are
available (e.g. epidemiological surveys, Poison Center
data, human studies), they should be taken into account for
the classification, especially if the data are different from
those generated by one of the two former methods. This
requirement is especially important since toxicological
studies on animals are out of favor and do not always reflect
the skin responsiveness in man. In addition, the calculation
method sums all classified ingredients without taking into
account interactions between surfactants which reduces
their irritation potential. The calculation rule often leads to
an over-labeling of finished products as skin irritants.
The absence of the warning label on the product does not
exclude the possibility that some transitory discomfort may
occur in consumers with sensitive skin or after repetitive
use. Products that are not “skin irritants” may also display
different levels of mildness. Well- substantiated skin com-
patibility claims and personal experience should allow con-
sumers to choose the most appropriate products.
Skin and toxic hazards
The percutaneous resorption of xenobiotics results from the
transfer of a chemical from the environment to the blood.
Understanding intoxication following skin contamination
calls for knowledge of the modalities of resorption and
diffusion of xenobiotics through the skin. The ingress of
xenobiotics through the stratum corneum is a passive diffu-
sion process. Two main routes of penetration can be fol-
lowed. One way follows the cutaneous appendages includ-
ing the hair follicles and the sweat glands. The other way is
transepidermal penetration, either through the hydrophilic
corneocytes or the lipophilic intercellular layers. Once be-
low the stratum corneum barrier, any toxic compound finds
its way through the living epidermis and in the dermis
where it is resorbed by blood and lymph. The same process
occurs with any kind of topically applied drug.
The percutaneous resorption varies according to a series of
parameters depending upon the size and the physicochemi-
cal properties of the xenobiotic. It also depends on the
quality of skin. Regional differences in absorption are rec-
ognized over the body. The integrity and degree of hydra-
tion of the stratum corneum are also of importance. The
coefficient of partition of the compound between its ve-
hicle, if any, and the stratum corneum, as well as the time
contact of the compound with the skin play additional roles
in the whole complex process.
In many skin disorders, the barrier function is compro-
mised. This is particularly important to consider in babies
who have an unfavorable ratio between the potential skin
area of resorption and the body volume. Higher body con-
centrations of toxic xenobiotics can accumulate in infants.
Another example of higher risk is encountered in some
occupational settings where mild abrasions of the skin are
common and occupational dermatoses are prevalent. Ma-
nipulation of toxic compounds is more risky in these con-
ditions if adequate protection is not maintained.
Conclusion
In many circumstances, environmental xenobiotics pose a
threat to the skin and thus to the individual. While the
stratum corneum barrier function usually offers a high
degree of protection, it can be breached by both physical
and chemical damage. The consequences for workers and
consumers can be considerable, so that both continuing
research and a refined regulatory approach are needed to
minimize the social and economic effects of a disturbed
interaction between the skin and the environment.
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